CVS Health (CVS) Tops Q3 EPS by 33c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
CVS Health Reports Third Quarter Results With Diversified Assets Delivering Strong Enterprise Performance
November 6, 2020 6:30 AM ESTWOONSOCKET, R.I., Nov. 6, 2020 /PRNewswire/ --
Continued Responsiveness to COVID-19:
Ongoing support for employees, consumers and communities across the country Doubled the number of test sites to more than 4,000 CVS Pharmacy locations nationwide Selected to administer vaccines to long-term care facilities Consumer-driven health care model increases access to products and servicesThird Quarter Highlights:
Total revenues increased to $67.1 billion, up 3.5% compared to prior year GAAP diluted earnings per share of $0.93 and GAAP operating income of $3.2 billion Adjusted EPS... More